Pilot Study of Gemcitabine, Oxaliplatin, and Cetuximab for Locally Advanced or Metastatic Pancreatic Cancer.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Cetuximab; Gemcitabine; Oxaliplatin
- Indications Pancreatic cancer
- Focus Therapeutic Use
- 15 Dec 2016 Biomarkers information updated
- 10 Apr 2008 Status change from recruiting to in progress, according to clinicaltrials.gov.
- 17 May 2007 New trial record.